Press releases

Release
24.01.2019

VALBIOTIS appoints Josep INFESTA, international expert in Consumer Healthcare, Head of Global Business Development

Download
Release
07.01.2019

VALBIOTIS is taking part in the 37th J.P. Morgan Healthcare conference, from 7 to 10 January 2019 in San Francisco, California

Download
Release
28.11.2018

VALBIOTIS recognized for its IPO at the 2018 INVESTOR AWARDS

Download
Release
12.11.2018

VALBIOTIS announces expansion of application for VALEDIA to include NASH prevention

Download
Release
06.11.2018

VALBIOTIS confirms the publication of the results from international Phase IIA clinical study evaluating VALEDIA® for the risk reduction of type 2 diabetes, by mid-2019

Download
Release
30.10.2018

VALBIOTIS signs scientific partnership with CarMeN, biomedical research laboratory in the field of metabolic diseases

Download
Release
17.10.2018

VALBIOTIS confirms its interest in the study of the intestinal microbiota

Download
Release
08.10.2018

Appointment of Murielle CAZAUBIEL as Head of Development and Medical Affairs

Download
Release
05.10.2018

Strengthening of the liquidity contract (in French)

Download